Method Development and Validation for Estimation of Etifoxine in Capsule Dosage Form by Using RP-HPLC/UV

Authors

  • Mannava Laharika Choudary Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cheeryal (V), Keesara (M), Medchal (D), Hyderabad-501301.
  • Medidi Srinivas Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cheeryal (V), Keesara (M), Medchal (D), Hyderabad-501301. https://orcid.org/0000-0002-6028-5744
  • Bula Udaya Kumari DSK Biopharma Inc, 112 Nova Dr, Morrisville, NC 27560, USA.

Abstract

A RP-HPLC/UV method was developed and validated to quantify the etifoxine in capsule dosage form. The chromatographic separation was carried out using a Hypersil ODS C18 column (250×4.6 mm, 5 μm) with a mobile phase consisting of an ammonium acetate buffer: acetonitrile in a volumetric ratio of 40:60%. The UV wavelength chosen for detection was at 255 nm. The flow rate was set at 1 ml/min. The retention time for etifoxine was determined to be 2.074 min.  Linearity was detected within the concentration range of 7.5-45 μg/mL for etifoxine. The approach has been confirmed to be linear, accurate, precise, robust, and has established limits of detection and quantitation. The established procedure was uncomplicated, cost-effective, and suitable for the routine analysis of etifoxine in capsule dosage form.

Keywords:

Etifoxine, RP-HPLC, Method development, Validation

DOI

https://doi.org/10.22270/jddt.v14i7.6703

Author Biographies

Mannava Laharika Choudary, Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cheeryal (V), Keesara (M), Medchal (D), Hyderabad-501301.

Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cheeryal (V), Keesara (M), Medchal (D), Hyderabad-501301.

Medidi Srinivas, Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cheeryal (V), Keesara (M), Medchal (D), Hyderabad-501301.

Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cheeryal (V), Keesara (M), Medchal (D), Hyderabad-501301.

Bula Udaya Kumari, DSK Biopharma Inc, 112 Nova Dr, Morrisville, NC 27560, USA.

Department of R&D, DSK Biopharma Inc, 112 Nova Dr, Morrisville, NC 27560, USA.

References

Nuss P, Ferreri F, Bourin M. An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action. Neuropsychiatric Disease and Treatment. 2019; 3:1781-95. https://doi.org/10.2147/NDT.S200568 PMid:31308671 PMCid:PMC6615018

Choi YM, Kim KH. Etifoxine for pain patients with anxiety. The Korean journal of pain. 2015; 28(1):4. https://doi.org/10.3344/kjp.2015.28.1.4 PMid:25589941 PMCid:PMC4293506

Hamon A, Morel A, Hue B, Verleye M, Gillardin JM. The modulatory effects of the anxiolytic etifoxine on GABAA receptors are mediated by the β subunit. Neuropharmacology. 2003; 45 (3):293-303. https://doi.org/10.1016/S0028-3908(03)00187-4 PMid:12871647

Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends in pharmacological sciences. 2006; 27(8):402-9. https://doi.org/10.1016/j.tips.2006.06.005 PMid:16822554

J. Pang, H. Li, L. Li, Determination of etifoxine hydrochloride in etifoxinehydrochloride capsules, Zhongguo Yaoxue Zazhi (Beijing, China). 2008; 43:1823-1826.

Djabrouhou N, Guermouche MH. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR. Journal of Pharmaceutical and Biomedical Analysis. 2014; 100:11-20. https://doi.org/10.1016/j.jpba.2014.07.017 PMid:25117950

Sai KE, Srinivas M, Kumari BU, Sumalatha C, Madhavi A. Development and Validation of an HPLC Method for the Determination of Lobeglitazone in Bulk and in Tablet Formulation. International Journal of Pharmaceutical Investigation. 2024; 14(1). https://doi.org/10.5530/ijpi.14.1.26

Harshita D, Srinivas M, Kumari BU, Sumalatha C, Umadevi R. Establishment and Validation of a High-performance Liquid Chromatography Technique for Quantifying Dalbavancin in Injectable Formulations. Asian Journal of Pharmaceutical Research and Health Care. 2023; 15(4):385-92. https://doi.org/10.4103/ajprhc.ajprhc_112_23

Sumalatha Ch, Srinivas M, Jitendar KM, Development of a Robust and Reliable RP-HPLC Method for the Estimation of Finerenone in Tablet Dosage Form. International Journal of Drug Delivery Technology. 2024; 14(2):703-708. https://doi.org/10.25258/ijddt.14.2.15

ICH. Validation of analytical procedure: Methodology International Conference on Harmonization. ICH harmonised tripartite guideline - validation of analytical procedures: text and methodology Q2(R1). ICH, Geneva, Switzerland, 2005.

Published

13-07-2024
Statistics
Abstract Display: 251
PDF Downloads: 302
PDF Downloads: 61

How to Cite

1.
Laharika Choudary M, Srinivas M, Udaya Kumari B. Method Development and Validation for Estimation of Etifoxine in Capsule Dosage Form by Using RP-HPLC/UV. J. Drug Delivery Ther. [Internet]. 2024 Jul. 13 [cited 2025 Jan. 21];14(7):64-70. Available from: https://jddtonline.info/index.php/jddt/article/view/6703

How to Cite

1.
Laharika Choudary M, Srinivas M, Udaya Kumari B. Method Development and Validation for Estimation of Etifoxine in Capsule Dosage Form by Using RP-HPLC/UV. J. Drug Delivery Ther. [Internet]. 2024 Jul. 13 [cited 2025 Jan. 21];14(7):64-70. Available from: https://jddtonline.info/index.php/jddt/article/view/6703